Signals
GlaxoSmithkline Consumer Healthcare Ltd(Merged)
NSE :GSKCONS BSE :500676 Sector : FMCGBuy, Sell or Hold GSKCONS? Ask The Analyst
BSE
prev close
OPEN PRICE
bid price (qty)
offer price (qty)
volume
Today's low / high
52 WK low / high
NSE
prev close
open price
bid price (qty)
offer price (qty)
volume
Today's' low / high
52 WK low / high
| 15 Apr 10732.60 (4.85%) | 13 Apr 10236.30 (-1.16%) | 09 Apr 10356.05 (-2.66%) | 08 Apr 10639.30 (0.43%) | 07 Apr 10593.40 (13.22%) | 03 Apr 9356.20 (-2.01%) | 01 Apr 9548.55 (-4.27%) | 31 Mar 9974.25 (5.55%) | 30 Mar 9449.90 (0.80%) | 27 Mar 9374.85 (-1.98%) | 26 Mar 9564.20 (3.99%) | 25 Mar 9197.65 (3.22%) | 24 Mar 8910.80 (8.79%) | 23 Mar 8190.80 (-8.31%) | 20 Mar 8933.25 (11.54%) | 19 Mar 8008.90 (-4.10%) | 18 Mar 8351.10 (-4.22%) | 17 Mar 8718.65 (3.56%) | 16 Mar 8418.65 (-4.72%) | 13 Mar 8835.60 (-0.74%) | 12 Mar 8901.50 (-4.74%) |
Price Chart Historical Data Technical Chart
Technical Analysis
Short Term Investors
Bearish
Medium Term Investors
Bearish
Long Term Investors
Bearish
Moving Averages
5 DMA
Bearish
0
10 DMA
Bearish
0
20 DMA
Bearish
0
50 DMA
Bearish
0
100 DMA
Bearish
0
200 DMA
Bearish
0
Intraday Support and Resistance
(Based on Pivot Points) |
Updated On Apr 15, 2020 04:00 PM For Next Trading Session
| Pivots | Classic | Fibonacci | Camarilla | Woodie | DM |
|---|---|---|---|---|---|
| R3 | 11491.74 | 11170.87 | 10881.1 | - | - |
| R2 | 11170.87 | 10964.59 | 10831.6 | 11196.3 | - |
| R1 | 10951.74 | 10837.15 | 10782.1 | 11002.6 | 11061.3 |
| P | 10630.87 | 10630.87 | 10630.87 | 10656.3 | 10685.65 |
| S1 | 10411.74 | 10424.59 | 10683.1 | 10462.6 | 10521.3 |
| S2 | 10090.87 | 10297.15 | 10633.6 | 10116.3 | - |
| S3 | 9871.74 | 10090.87 | 10584.1 | - | - |
Key Metrics
Shareholding History
Quarterly Result (Figures in Rs. Crores)
GlaxoSmithkline Consumer Healthcare Ltd(Merged) Quaterly Results
| INCOME | |||||
| PROFIT | |||||
| EPS |
GlaxoSmithkline Consumer Healthcare Ltd(Merged) Quaterly Results
| INCOME | 1241.07 | 1408.95 | 1320.9 | 1423.22 | 1274.9 |
| PROFIT | 221.06 | 285.81 | 248.08 | 345.31 | 276.63 |
| EPS | 52.56 | 67.95 | 58.98 | 82.1 | 65.77 |
Profit & Loss (Figures in Rs. Crores)
GlaxoSmithkline Consumer Healthcare Ltd(Merged) Profit & Loss
| INCOME | |
| PROFIT | |
| EPS |
GlaxoSmithkline Consumer Healthcare Ltd(Merged) Profit & Loss
| Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | ||
| INCOME | 2024.65 | 2453.31 | 2894.25 | 3315.75 | 5066.58 | 4572.45 | 4416.48 | 4238 | 4532.94 | 5273.53 | |
| PROFIT | 232.68 | 298.16 | 355.2 | 436.29 | 674.75 | 588.87 | 686.6 | 656.68 | 699.85 | 982.51 | |
| EPS | 52.29 | 62.99 | 78.78 | 96.55 | 122.24 | 127.57 | 163.42 | 156.15 | 166.47 | 233.69 |
Balance Sheet (Figures in Rs. Crores)
| Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| SOURCES OF FUNDS : | ||||||||||
| Share Capital | 42.06 | 42.06 | 42.06 | 42.06 | 42.06 | 42.06 | 42.06 | 42.06 | 42.06 | 42.06 |
| Reserves Total | 4,052.66 | 3,443.06 | 3,080.61 | 2,756.65 | 2,070.98 | 1,770.79 | 1,318.92 | 1,102.12 | 917.98 | 863.04 |
| Total Shareholders Funds | 4,094.72 | 3,485.12 | 3,122.67 | 2,798.71 | 2,113.04 | 1,812.85 | 1,360.98 | 1,144.18 | 960.04 | 905.1 |
| Secured Loans | 0 | 0 | 8.36 | 12.75 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt | 0 | 0 | 8.36 | 12.75 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 159.39 | 184.95 | 236.39 | 237.89 | 220.47 | 167.03 | 88.28 | 60.73 | 0 | 0 |
| Total Liabilities | 4,254.11 | 3,670.07 | 3,367.42 | 3,049.35 | 2,333.51 | 1,979.88 | 1,449.26 | 1,204.91 | 960.04 | 905.1 |
| APPLICATION OF FUNDS : | ||||||||||
| Gross Block | 696.76 | 650.85 | 629.35 | 569.43 | 1,059.28 | 854.62 | 656.24 | 636.66 | 598.96 | 558.48 |
| Less : Accumulated Depreciation | 234.69 | 175.32 | 141.93 | 88.16 | 567.54 | 514.71 | 462.4 | 435.97 | 396.71 | 364 |
| Net Block | 462.07 | 475.53 | 487.42 | 481.27 | 491.74 | 339.91 | 193.84 | 200.69 | 202.25 | 194.48 |
| Capital Work in Progress | 17.73 | 38.25 | 57.67 | 51.39 | 42.31 | 38.45 | 197.24 | 149.16 | 108.33 | 37.78 |
| Inventories | 465.47 | 409.42 | 461.14 | 461.62 | 466.25 | 407.42 | 369.64 | 369.96 | 312 | 266.03 |
| Sundry Debtors | 385.68 | 278.72 | 321 | 354.16 | 313.36 | 299.35 | 112.61 | 99.19 | 50.37 | 31.36 |
| Cash and Bank Balance | 4,097.34 | 3,585.2 | 3,087.38 | 2,712.27 | 2,296.52 | 1,838.78 | 1,464.24 | 1,079.66 | 976.1 | 819.8 |
| Loans and Advances | 318.94 | 288.67 | 269.61 | 229.55 | 229.29 | 208.39 | 96.47 | 93.49 | 84.66 | 55.72 |
| Total Current Assets | 5,267.42 | 4,562 | 4,139.14 | 3,757.6 | 3,305.42 | 2,753.93 | 2,042.96 | 1,642.3 | 1,423.13 | 1,172.91 |
| Current Liabilities | 1,481.69 | 1,428.22 | 1,282.48 | 1,140.51 | 1,290.91 | 1,134.78 | 829.99 | 653.64 | 470.37 | 375.32 |
| Provisions | 332.29 | 314.38 | 304.79 | 305.47 | 395.14 | 296.81 | 275.31 | 223.92 | 330.03 | 135.76 |
| Total Current Liabilities & Provisions | 1,813.98 | 1,742.59 | 1,587.27 | 1,445.98 | 1,686.05 | 1,431.59 | 1,105.3 | 877.56 | 800.4 | 511.08 |
| Net Current Assets | 3,453.44 | 2,819.41 | 2,551.87 | 2,311.62 | 1,619.37 | 1,322.34 | 937.66 | 764.74 | 622.73 | 661.83 |
| Deferred Tax Assets | 142.59 | 142.08 | 153.81 | 127.83 | 122.43 | 106.84 | 68.46 | 47.79 | 38.26 | 23.84 |
| Deferred Tax Liability | 28.7 | 26.63 | 26.01 | 14.69 | 18.09 | 16.54 | 6.83 | 7.9 | 11.53 | 12.83 |
| Net Deferred Tax | 113.89 | 115.45 | 127.8 | 113.14 | 104.34 | 90.3 | 61.63 | 39.89 | 26.73 | 11.01 |
| Other Assets | 206.98 | 221.43 | 142.66 | 91.92 | 75.74 | 188.88 | 58.9 | 50.43 | 0 | 0 |
| Total Assets | 4,254.11 | 3,670.07 | 3,367.43 | 3,049.34 | 2,333.51 | 1,979.88 | 1,449.26 | 1,204.91 | 960.04 | 905.1 |
| Contingent Liabilities | 145.61 | 140.34 | 135.06 | 129.79 | 605.36 | 393.17 | 284.68 | 160.69 | 147.43 | 33.44 |
Cash Flow (Figures in Rs. Crores)
| Net Profit before Tax and Extr... | 982.8 |
| Depreciation | 60.5 |
| Interest (Net) | -263.37 |
| P/L on Sales of Assets | -0.45 |
| Prov. and W/O (Net) | -136.79 |
| P/L in Forex | 0.54 |
| Others | -64.83 |
| Total Adjustments (PBT and Ext... | 186.4 |
| Operating Profit before Workin... | 1,169.21 |
| Trade and 0ther Receivables | -108.85 |
| Inventories | -50.46 |
| Trade Payables | 25.19 |
| Loans and Advances | -2.78 |
| Total Adjustments (OP before W... | 1.38 |
| Cash Generated from/(used in) ... | 1,170.58 |
| Direct Taxes Paid | -499.51 |
| Total Adjustments(Cash Generat... | -499.51 |
| Cash Flow before Extraordinary... | 671.07 |
| Net Cash from Operating Activi... | 671.07 |
| Purchased of Fixed Assets | -33.96 |
| Sale of Fixed Assets | 1.3 |
| Interest Received | 246.29 |
| Net Cash used in Investing Act... | -335.06 |
| Dividend Paid | -311.18 |
| Interest Paid | -0.78 |
| Net Cash used in Financing Act... | -376.8 |
Company Details
Registered Office |
|
| Address | Patiala Road, |
| City | Nabha |
| State | Punjab |
| Pin Code | 147201 |
| Tel. No. | 91-1765-220151/220152/220059 |
| Fax. No. | 91-1765-220642 |
| investor.2.co@gsk.com | |
| Internet | http://www.gsk-ch.in |
Registrars |
|
| Address | Patiala Road |
| City | Nabha |
| State | Punjab |
| Pin Code | 147201 |
| Tel. No. | 91-1765-220151/220152/220059 |
| Fax. No. | 91-1765-220642 |
| investor.2.co@gsk.com | |
| Internet | http://www.gsk-ch.in |
Management |
|
| Name | Designation |
| Kunal Kashyap | Independent Director |
| Naresh Dayal | Independent Director |
| P Dwarakanth | Chairman |
| Sangeeta Talwar | Independent Director |
| Shanu Saksena | Company Secretary |
| Anup Dhingra | Director (Operation) |
| Navneet Saluja | Managing Director |
| S Madhavan | Independent Director |
| Pradeep V Bhide | Independent Director |
